Guardant Health, Inc. announced it raised $320 Million in an initial filing from an offering of $320 Million
Guardant Health, Inc. announced it raised $320 Million in an initial filing from an offering of $320 Million
08/09/17, 4:37 PM
Location
palo altoMoney raised
$320 million
Industry
biotechnology research
Company Info
Location
505 penobscot dr.
palo alto, california, united states
Additional Info
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.